Navigation Links
Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons
Date:9/26/2011

pleased to present these data that reinforce the safety and efficacy of EXPAREL to the plastic surgeon community," said Dave Stack, president and chief executive officer of Pacira Pharmaceuticals, Inc. "Based upon our market research, we believe that plastic surgeons will have significant and immediate interest in the use of EXPAREL, should it be approved by the FDA later this year, for breast augmentation and abdominoplasty [tummy tuck] surgeries, a market that includes approximately one million annual procedures. Beyond this initial market opportunity, we believe that EXPAREL can address a significant, unmet medical need to provide long-acting non-opioid postsurgical pain relief in more than 24 million procedures per year in the U.S. alone."

For more information or to view the full abstracts, please visit the scientific presentations page located in the investors and media section on the Pacira website at www.pacira.com.

About Pacira

Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. In December 2010, Pacira announced that its New Drug Application (NDA) for EXPAREL (bupivacaine liposome extended-release injectable suspension), the company's most advanced investigational product candidate, had been accepted for filing by the U.S. Food and Drug Administration (FDA). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of October 28, 2011 for the review of the EXPAREL NDA. EXPAREL is a bupivacaine-based product and has completed extensive Phase 3 clinical development for postsurgical analgesia by infiltration. EXPAREL consists of bupivacaine encapsulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
3. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
4. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
6. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
8. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
9. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
10. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
11. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... -- In a sweeping analysis assessing the current state of ... researchers conclude that there remains considerable room for improving ... groups, but especially for adolescents and young adults. The ... underscoring the need to address barriers to care and ... 1 patients achieve optimal metabolic control. ...
(Date:5/21/2015)... , May 21, 2015  When ... along the side of his neck, he ... took a couple weeks off from weight ... go away.                               A ... 26, was referred to Michel Kliot, ...
(Date:5/21/2015)...  Cardica, Inc. (Nasdaq: CRDC ) today announced that ... the company,s vice president of operations, was granted an option ... a per share exercise price of $0.43, the closing trading ... pursuant to Cardica, Inc.,s Inducement Plan, which was approved by ... 5653(c)(4) of the Nasdaq Global Market for equity grants to ...
Breaking Medicine Technology:Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4Cardica Announces New Employment Inducement Grant 2
... June 28, 2011 In strong collaboration with clinical ... compact version of the LokomatPro that offers greater system ... device in 2001, the LokomatPro has established itself as ... patients with neurological diseases and injuries resulting in gait ...
... 2011 The Educational Review System announces the first ... an education grant from Talyst. The Summit will focus ... will be hosted by barcode point-of-care (BPOC) expert, Mark ... Practices (ISMP) Lifetime Achievement Award. "Patient safety ...
Cached Medicine Technology:Hocoma Launches New Version of its Established Gait Training Device LokomatPro 2
(Date:5/22/2015)... West Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they ... in cosmetic, restorative and other dental treatments. At ... that interest them. Questions regarding what certain treatments ... can also be covered during this initial appointment. ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Wimbledon Health ... vascular, electrocardiogram (EKG), echocardiogram and NCV testing , ... a highly respected All American National athlete, to the ... I find the high level of testing and information ... athlete and their athletic trainers, this way they can ...
(Date:5/22/2015)... Houston, Texas (PRWEB) May 22, 2015 ... Denver, Colorado. In the past 9 years they have ... across the United States and Canada. Because of this ... they have established corporate offices in Denver, Colorado, Cleveland, ... Veatch Consulting specializes in opening new dental offices, dental ...
(Date:5/22/2015)... In efforts to offer full and ... particular muscles stretches has been a large focus over ... now complete, Chunk Fitness envisions a mid-June launch of ... and released at a later point in time. The ... http://www.chunkfitness.com/stretches . , About the Company: Chunk Fitness was ...
(Date:5/21/2015)... York, New York (PRWEB) May 21, 2015 ... distributor of patented products, launches the Troll Motor Guide, ... convenient way of boating. , "The recreational boating industry ... Scott J. Cooper, CEO and Creative Director of ... water in record numbers and predicts continued steady growth ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3
... in patients with metastatic breast cancer, especially in those ... epidermal growth factor receptor-2) positive, a surgical oncologist will ... Breast Cancer Conference (EBCC7). Dr Marie Sundquist, ... will say that the median survival times for five-year ...
... ... leading Pediatrician Dr. William Lawrence Jr. of Sixty Second Parent encouraged parents to continue ... ... National Nutrition Month draws to a close, leading Pediatrician Dr. William Lawrence Jr. of ...
... ... of Shimmering Resumes, offers to help former Bush speechwriter David Frum with his resume. ... strategy on healthcare reform. , ... (PRWEB) March 26, 2010 -- Paul Freiberger, the President of Shimmering Resumes, ...
... ... accidents , ... March 26, 2010 -- With the arrival of spring, more cyclists are planning to enjoy the ... people sharing the road with drivers and pedestrians., , , , ,This week bikers complained to ...
... ... disorders and improve dental procedures. , ... Miami, FLA. (PRWEB) -- In addition to cosmetic dentistry services, including veneers and ... Institute now offer dental massage to patients. Dr. Nassery teams up with Love Life Massage, ...
... Women who discover they have breast cancer while they ... the health of their unborn baby, according to research ... Conference (EBCC7) in Barcelona today (Friday). Dr Sibylle ... University of Frankfurt, Germany, and a member of the ...
Cached Medicine News:Health News:Survival in metastatic breast cancer patients is improving: targeted therapies have contributed 2Health News:Eating Habits Start Early - Parents must be Good Role Models for Healthy Kids 2Health News:President of Shimmering Resumes Offers Professional Resume To Bush Speechwriter, David Frum 2Health News:New York Personal Injury Attorney Interprets Increase in Tickets for Cyclists as Effort to Make Streets Safer 2Health News:Top Miami Dentist, Dr. Hamid Nassery, Offers Dental Massage Services For Patients 2Health News:Pregnant women can receive breast cancer chemotherapy without endangering health of their babies 2Health News:Pregnant women can receive breast cancer chemotherapy without endangering health of their babies 3
Express Elyte Systems....
... has minimal requirements for sample ... L/test), reagent consumption (as low ... consumption (25 L/hour) - thus ... rack handler facilitates continuous sample ...
Iron Total (TIBC) (Iron Buffer + Iron Color=Std.). An Automated analyzer test kits....
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
Medicine Products: